EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudieMultizentrische Studie

Comparative Performance of LFA ‐ REAL , SLEDAI , and BILAG for Detecting Clinically Meaningful Changes in Lupus Activity

Alberto Nordmann-Gomes iD, Leila Khalili, Cynthia Aranow iD, Meggan Mackay iD, Mimi Kim, Diane Kamen, Cristina Arriens iD, Maya Souvignier, Wei Tang, Stephen Suh, Robert Clancy iD, Cady Chen und 3 weitere

Arthritis Care & Research · 2026

DOI: 10.1002/acr.80034 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Arthritis Care & Research, 2026. Verfasst von Alberto Nordmann-Gomes und 14 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Irving Medical Center, New York, New York. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Severity of Illness Index. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: NIAMS NIH HHS, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to compare the performance of the Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA‐REAL), British Isles Lupus Assessment Group Index (BILAG), and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) in detecting the clinician's perception of improvement and worsening disease and identifying patients requiring treatment escalation.

Methods

This was a prospective, observational study conducted at four centers. Adults with systemic lupus erythematosus were evaluated at a baseline and follow‐up visit. Disease activity was assessed using SLEDAI, BILAG, and LFA‐REAL at both visits by the same physician. At the follow‐up visit, the Clinician Global Impression of Change (CGIC) was recorded to classify patients as improved, worsened, or unchanged. Receiver operating characteristic curve analysis was used to evaluate each instrument in detecting clinician‐rated change gauged by CGIC with optimal cut‐off points determined using the Youden Index.

Results

Of the 163 patients enrolled, 145 (89%) completed a follow‐up visit. Based on CGIC, 23% improved, 16% worsened, and 61% remained stable. For detecting CGIC‐defined improvement, LFA‐REAL had an area under the curve (AUC) of 0.85 (95% confidence interval [CI] 0.77–0.92), compared to 0.75 (95% CI 0.66–0.85) for BILAG and 0.74 (95% CI 0.64–0.84) for SLEDAI. For CGIC‐defined worsening, AUCs were 0.86 (95% CI 0.77–0.96), 0.79 (95% CI 0.67–0.90), and 0.76 (95% CI 0.66–0.87). Of those with CGIC‐defined worsening, eight (35%) required treatment escalation. LFA‐REAL identified a difference of ≥10 mm in all eight of these patients, compared to four by BILAG and two by SLEDAI.

Conclusion

LFA‐REAL showed comparable performance relative to SLEDAI and BILAG in detecting clinician‐rated change. There was a statistically significant advantage over SLEDAI for detection of improvement. These findings support its utility as a metric for disease activity in clinical practice and research. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicSeverity of Illness IndexHumansFemaleProspective StudiesMaleAdultMiddle AgedPredictive Value of TestsDisease ProgressionROC CurveArea Under CurveReproducibility of Results

Autor:innen und Institutionen

  • Columbia University Irving Medical Center, New York, New York.
  • Feinstein Institutes for Medical Research, Manhasset, New York.
  • Albert Einstein College of Medicine, Bronx, New York.
  • Medical University of South Carolina, Charleston.
  • Oklahoma Medical Research Foundation, Oklahoma City.
  • University of California San Francisco.

ORCID-Profile: Alberto Nordmann-Gomes, Cynthia Aranow, Meggan Mackay, Cristina Arriens, Robert Clancy, Anca D Askanase

Förderung

  • NIAMS NIH HHS
  • U.S. Department of Defense

Zitieren

APA

Nordmann-Gomes, A., Khalili, L., Aranow, C., Mackay, M., Kim, M., Kamen, D., Arriens, C., Souvignier, M., Tang, W., Suh, S., Clancy, R., Chen, C., Dall'Era, M., Merrill, J. T., & Askanase, A. D. (2026). Comparative Performance of LFA ‐ REAL , SLEDAI , and BILAG for Detecting Clinically Meaningful Changes in Lupus Activity. Arthritis Care & Research. https://doi.org/10.1002/acr.80034

Vancouver

Nordmann-Gomes A, Khalili L, Aranow C, Mackay M, Kim M, Kamen D, et al. Comparative Performance of LFA ‐ REAL , SLEDAI , and BILAG for Detecting Clinically Meaningful Changes in Lupus Activity. Arthritis Care & Research. 2026. doi:10.1002/acr.80034

BibTeX
@article{NordmannGomes2026,
  author = {Nordmann-Gomes, Alberto and Khalili, Leila and Aranow, Cynthia and Mackay, Meggan and Kim, Mimi and Kamen, Diane and Arriens, Cristina and Souvignier, Maya and Tang, Wei and Suh, Stephen and Clancy, Robert and Chen, Cady and Dall'Era, Maria and Merrill, Joan T and Askanase, Anca D},
  title = {Comparative Performance of LFA ‐ REAL , SLEDAI , and BILAG for Detecting Clinically Meaningful Changes in Lupus Activity},
  journal = {Arthritis Care & Research},
  year = {2026},
  doi = {10.1002/acr.80034}
}
Kostenlos starten →